Buyback yield (TTM)
2.50%
Shareholder yield (TTM)
3.59%
5Y share count change
-14.5%
Buyback spend (TTM)
$548.00M
Cumulative buybacks
$12.41B
Key takeaways
- Labcorp Holdings (LH) repurchased about $548.00M of stock over the trailing twelve months.
- Diluted share count is down 14.5% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 4.39× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +27.3% per year over the latest 5-year window.
- TTM repurchases used about 48% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Labcorp Holdings (LH)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Labcorp Holdings (LH)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Labcorp Holdings (LH)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Labcorp Holdings (LH)
Latest: $450.00M
Overview
2025's annual buyback spend for Labcorp Holdings (LH) came in at $450.00M – surged 79.9% year-over-year.
Through 2020–2025 (5 years), Labcorp Holdings buyback spend delivered a +27.3% annualised rate; with mixed annual results across the window.
Labcorp Holdings buyback spend peaked at $1.67B in 2021; the latest annual figure is $450.00M in 2025 (73.0% below peak).
Across the available history, buyback spend reached its high of $1.67B in 2021 and its low of $0.00 in 1989.
Labcorp Holdings Buyback Spend 2025: $450.00M
Labcorp Holdings posted buyback spend of $450.00M in 2025, surged 79.9% from 2024.
Labcorp Holdings Buyback Spend 2024: $250.10M
In 2024, Labcorp Holdings reported buyback spend of $250.10M, plunged 75.9% below 2023.
Labcorp Holdings Buyback Spend 2023: $1.04B
Labcorp Holdings buyback spend in 2023 was $1.04B, declined 9.6% below 2022.
Labcorp Holdings Buyback Spend 2022: $1.15B
2022's buyback spend for Labcorp Holdings came in at $1.15B, plunged 31.0% below 2021.
Labcorp Holdings Buyback Spend 2021: $1.67B
Labcorp Holdings buyback spend in 2021 was $1.67B.
See more financial history for Labcorp Holdings (LH).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $450.00M | $125.80M | $324.20M | 2.17% | 0.08B | -0.7% | |
| 2024 | $250.10M | $116.70M | $133.40M | 1.30% | 0.08B | -3.7% | |
| 2023 | $1.04B | $128.70M | $911.10M | 5.39% | 0.09B | -4.4% | |
| 2022 | $1.15B | $116.80M | $1.03B | 6.43% | 0.09B | -6.1% | |
| 2021 | $1.67B | $132.90M | $1.54B | 6.49% | 0.10B | -0.5% | |
| 2020 | $134.50M | $111.70M | $22.80M | 0.79% | 0.10B | -0.6% | |
| 2019 | $450.00M | $107.00M | $343.00M | 3.19% | 0.10B | -3.9% | |
| 2018 | $700.00M | $91.60M | $608.40M | 6.44% | 0.10B | -1.3% | |
| 2017 | $338.10M | $109.70M | $228.40M | 2.41% | 0.10B | -0.4% | |
| 2016 | $43.90M | $109.60M | −$65.70M | 0.39% | 0.10B | +3.7% | |
| 2015 | $0.00 | $102.10M | −$102.10M | — | 0.10B | +16.4% | |
| 2014 | $269.00M | $45.70M | $223.30M | 3.43% | 0.09B | -5.9% | |
| 2013 | $1.02B | $37.30M | $978.30M | 15.10% | 0.09B | -5.7% | |
| 2012 | $516.50M | $40.70M | $475.80M | 7.42% | 0.10B | -4.3% | |
| 2011 | $643.90M | $48.90M | $595.00M | 8.98% | 0.10B | -3.4% | |
| 2010 | $338.10M | $40.00M | $298.10M | 4.47% | 0.11B | -3.4% | |
| 2009 | $273.00M | $36.40M | $236.60M | 4.02% | 0.11B | -3.6% | |
| 2008 | $333.60M | $36.20M | $297.40M | 5.60% | 0.11B | -6.7% | |
| 2007 | $921.20M | $0.00 | $921.20M | 12.53% | 0.12B | -8.9% | |
| 2006 | $476.50M | $52.70M | $423.80M | 6.18% | 0.13B | -6.5% | |
| 2005 | $583.70M | $0.00 | $583.70M | 9.63% | 0.14B | -3.8% | |
| 2004 | $368.10M | $0.00 | $368.10M | 6.22% | 0.15B | -2.6% | |
| 2003 | $154.90M | $0.00 | $154.90M | 3.47% | 0.15B | +5.8% | |
| 2002 | $0.00 | $0.00 | $0.00 | — | 0.14B | +1.8% | |
| 2001 | $0.00 | $0.00 | $0.00 | — | 0.14B | +151.8% | |
| 2000 | $0.00 | $0.00 | $0.00 | — | 0.06B | +3.0% | |
| 1999 | $0.00 | $0.00 | $0.00 | — | 0.05B | +8.1% | |
| 1998 | $0.00 | $0.00 | $0.00 | — | 0.05B | +2.5% | |
| 1997 | $0.00 | $0.00 | $0.00 | — | 0.05B | +0.1% | |
| 1996 | $0.00 | $0.00 | $0.00 | — | 0.05B | — | |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1993 | $154.20M | $0.00 | $154.20M | — | — | — | |
| 1992 | $131.90M | $0.00 | $131.90M | — | — | — | |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1990 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1989 | $0.00 | $0.00 | $0.00 | — | — | — |
- 2025$450.00M
- 2024$250.10M
- 2023$1.04B
- 2022$1.15B
- 2021$1.67B
- 2020$134.50M
- 2019$450.00M
- 2018$700.00M
- 2017$338.10M
- 2016$43.90M
- 2015$0.00
- 2014$269.00M
- 2013$1.02B
- 2012$516.50M
- 2011$643.90M
- 2010$338.10M
- 2009$273.00M
- 2008$333.60M
- 2007$921.20M
- 2006$476.50M
- 2005$583.70M
- 2004$368.10M
- 2003$154.90M
- 2002$0.00
- 2001$0.00
- 2000$0.00
- 1999$0.00
- 1998$0.00
- 1997$0.00
- 1996$0.00
- 1995$0.00
- 1994$0.00
- 1993$154.20M
- 1992$131.90M
- 1991$0.00
- 1990$0.00
- 1989$0.00
Buybacks vs stock-based compensation for Labcorp Holdings (LH)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 4.39×.
Buybacks vs dividends (share of cash returned) for Labcorp Holdings (LH)
How Labcorp Holdings splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Labcorp Holdings, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.14B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation